Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study.
Hematol Oncol. 2018 Apr 30. doi: 10.1002/hon.2513. Online ahead of print.
Hematol Oncol. 2018.
PMID: 29709062
Lenalidomide and metronomic melphalan for CMML and higher risk MDS: a phase 2 clinical study with biomarkers of angiogenesis.
Buckstein R, Kerbel R, Cheung M, Shaked Y, Chodirker L, Lee CR, Lenis M, Davidson C, Cussen MA, Reis M, Chesney A, Zhang L, Mamedov A, Wells RA.
Buckstein R, et al. Among authors: cussen ma.
Leuk Res. 2014 Jul;38(7):756-63. doi: 10.1016/j.leukres.2014.03.022. Epub 2014 Apr 5.
Leuk Res. 2014.
PMID: 24819395
Free article.
Clinical Trial.
Item in Clipboard
Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial.
Spaner DE, Wang G, McCaw L, Li Y, Disperati P, Cussen MA, Shi Y.
Spaner DE, et al. Among authors: cussen ma.
Haematologica. 2016 May;101(5):e192-5. doi: 10.3324/haematol.2015.135418. Epub 2016 Jan 27.
Haematologica. 2016.
PMID: 26819050
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite